Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Insulin Glargine And Lixisenatide

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Sanofi’s diabetes drug soliquoa will face fierce competition in price
    Sanofi’s diabetes drug soliquoa will face fierce competition in price

    21 Apr 2023

    // PHARMABIZ

    http://pharmabiz.com/NewsDetails.aspx?aid=157684&sid=2

    PHARMABIZ
    21 Apr 2023
    Share Share
    Sanofi launches new long-acting insulin drug in India
    Sanofi launches new long-acting insulin drug in India

    27 Mar 2023

    // ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/sanofi-launches-new-long-acting-insulin-drug-in-india/articleshow/99041272.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

    ECONOMIC TIMES
    27 Mar 2023
    Share Share
    Mylan Pharms Inc Biological Insulin Glargine-Yfgn Receives Approval in US
    Mylan Pharms Inc Biological Insulin Glargine-Yfgn Receives Approval in US

    28 Jul 2021

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761201

    FDA
    28 Jul 2021
    Share Share